These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5398323)

  • 41. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative results of medium and increased doses of isoniazid in the triple treatment of overt pulmonary tuberculosis].
    Favez G; Maillard JM; Vouilloz M
    Schweiz Med Wochenschr; 1968 Sep; 98(36):1392-5. PubMed ID: 5693896
    [No Abstract]   [Full Text] [Related]  

  • 43. [Therapeutic results of freshly diagnosed pulmonary tuberculosis EMB in association with SM and INH administered both continuously and intermittently].
    Zierski M
    Gruzlica; 1970; 38(7):723-4. PubMed ID: 5453682
    [No Abstract]   [Full Text] [Related]  

  • 44. [Results of short-term tuberculostatic treatment at the end of the therapeutic regimen].
    Tănase C; Baraneţchi C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):43-7. PubMed ID: 6312534
    [No Abstract]   [Full Text] [Related]  

  • 45. [The hemogram and ESR in pulmonary tuberculosis during intravenous administration of the primary antitubercular drugs].
    Koviazina AI; Utkin VV
    Probl Tuberk; 1971; 49(2):48-51. PubMed ID: 5561919
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical experience in the single administration of daily doses of chemical preparations].
    Pozdniakova EI; Matiashvili NA
    Probl Tuberk; 1970; 48(4):89-90. PubMed ID: 5471139
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of lymphotropic therapy in the multimodality treatment of patients with pulmonary tuberculosis and comorbidity].
    Ubaĭdullaev AM; Belotserkovets VG
    Probl Tuberk Bolezn Legk; 2004; (12):50-2. PubMed ID: 15719669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Controlled study of a bi-weekly treatment with isoniazid and ethionamide].
    Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Zirout A
    Bull Int Union Tuberc; 1970 Jun; 43():282-8. PubMed ID: 5425556
    [No Abstract]   [Full Text] [Related]  

  • 49. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Direct evaluation of the results of treatment of cutaneous tuberculosis with streptomycin, isoniazid and ethambutol].
    Arkuszewska C
    Przegl Dermatol; 1980; 67(1):97-101. PubMed ID: 7375659
    [No Abstract]   [Full Text] [Related]  

  • 52. A five regimen study of triple-versus double-drug chemotherapy--U.S. Veterans Administration study.
    MacDonald FM
    Bull Int Union Tuberc; 1970 Jun; 43():305-9. PubMed ID: 5425559
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparative findings from various approaches of treating infiltrative and cavernous pulmonary tuberculosis in rabbits].
    Bondarev IM; Klebanova AA; Novoselova VP
    Probl Tuberk; 1971; 49(3):47-52. PubMed ID: 5562450
    [No Abstract]   [Full Text] [Related]  

  • 54. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
    Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Kekkaku; 1984 Feb; 59(2):81-9. PubMed ID: 6379258
    [No Abstract]   [Full Text] [Related]  

  • 56. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Rifampin in the treatment of children with newly detected intrathoracic tuberculosis].
    Gvasaliia T
    Probl Tuberk; 1984 Apr; (4):46-50. PubMed ID: 6610872
    [No Abstract]   [Full Text] [Related]  

  • 59. Modern treatment of tuberculosis.
    Dutt AK; Stead WW
    Compr Ther; 1982 Sep; 8(9):19-28. PubMed ID: 7140206
    [No Abstract]   [Full Text] [Related]  

  • 60. [Pharmacokinetic characteristics of streptomycin and isoniazid administered in ultrasonic aerosols to patients with respiratory organ tuberculosis].
    Brant AL; Semenova EA
    Antibiotiki; 1981 Aug; 26(8):628-32. PubMed ID: 7294755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.